Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013 (2013), Article ID 684071, 13 pages
http://dx.doi.org/10.1155/2013/684071
Research Article

Gan-Lu-Yin Inhibits Proliferation and Migration of Murine WEHI-3 Leukemia Cells and Tumor Growth in BALB/C Allograft Tumor Model

1School of Pharmacy, China Medical University, 91 Hsueh-Shih Road, Taichung 40402, Taiwan
2Department of Pharmacy, Da Chien General Hospital, Miaoli 36052, Taiwan
3Department of Pathology, Chung Shan Medical University, Taichung 40201, Taiwan
4Department of Pathology, Chung Shan Medical University Hospital, Taichung 40201, Taiwan
5Graduate Institute of Biological Science and Technology, China Medical University, Taichung 40402, Taiwan

Received 21 November 2012; Accepted 4 February 2013

Academic Editor: Evan Paul Cherniack

Copyright © 2013 Fon-Chang Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. Pulte, A. Gondos, and H. Brenner, “Expected long-term survival of patients diagnosed with acute myeloblastic leukemia during 2006–2010,” Annals of Oncology, vol. 21, no. 2, pp. 335–341, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. M. Y. Lee, T. D. Tan, and A. C. Feng, “Clinicopathologic analysis of acute myeloid leukemia in a single institution: biphenotypic acute myeloid leukemia may not be an aggressive subtype,” Journal of the Chinese Medical Association, vol. 70, no. 7, pp. 269–273, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Amadori, P. Fenaux, H. Ludwig, M. O'Dwyer, and M. Sanz, “Use of arsenic trioxide in haematological malignancies: insight into the clinical development of a novel agent,” Current Medical Research and Opinion, vol. 21, no. 3, pp. 403–411, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Glasow, N. Prodromou, K. Xu, M. Von Lindern, and A. Zelent, “Retinoids and myelomonocytic growth factors cooperatively activate RARA and induce human myeloid leukemia cell differentiation via MAP kinase pathways,” Blood, vol. 105, no. 1, pp. 341–349, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. J. X. Li, Y. Q. Shen, B. Z. Cai et al., “Arsenic trioxide induces the apoptosis in vascular smooth muscle cells via increasing intracellular calcium and ROS formation,” Molecular Biology Reports, vol. 37, no. 3, pp. 1569–1576, 2010. View at Publisher · View at Google Scholar · View at Scopus
  6. E. Patatanian and D. F. Thompson, “Retinoic acid syndrome: a review,” Journal of Clinical Pharmacy and Therapeutics, vol. 33, no. 4, pp. 331–338, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Gandillet, A. G. Serrano, S. Pearson, M. Lie-A-Ling, G. Lacaud, and V. Kouskoff, “Sox7-sustained expression alters the balance between proliferation and differentiation of hematopoietic progenitors at the onset of blood specification,” Blood, vol. 114, no. 23, pp. 4813–4822, 2009. View at Publisher · View at Google Scholar · View at Scopus
  8. Y. Y. Cha, E. O. Lee, H. J. Lee et al., “Methylene chloride fraction of Scutellaria barbata induces apoptosis in human U937 leukemia cells via the mitochondrial signaling pathway,” Clinica Chimica Acta, vol. 348, no. 1-2, pp. 41–48, 2004. View at Publisher · View at Google Scholar · View at Scopus
  9. C. H. Pan, I. C. Hsieh, F. C. Liu et al., “Effects of a Chinese herbal health formula, “gan-Lu-Yin”, on angiogenesis,” Journal of Agricultural and Food Chemistry, vol. 58, no. 13, pp. 7685–7692, 2010. View at Publisher · View at Google Scholar · View at Scopus
  10. J. M. Kim, S. U. Lee, Y. S. Kim, Y. K. Min, and S. H. Kim, “Baicalein stimulates osteoblast differentiation via coordinating activation of MAP kinases and transcription factors,” Journal of Cellular Biochemistry, vol. 104, no. 5, pp. 1906–1917, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. P. A. Haridas Nidhina, N. Poulose, and A. Gopalakrishnapillai, “Vanillin induces adipocyte differentiation in 3T3-L1 cells by activating extracellular signal regulated kinase 42/44,” Life Sciences, vol. 88, no. 15-16, pp. 675–680, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. T. W. Tan, Y. T. Lin, J. S. Yang et al., “A. cantoniensis inhibits the proliferation of murine leukemia WEHI-3 cells in vivo and promotes immunoresponses in vivo,” In Vivo, vol. 23, no. 4, pp. 561–566, 2009. View at Google Scholar · View at Scopus
  13. G. Levay and W. J. Bodell, “Potentiation of DNA adduct formation in HL-60 cells by combinations of benzene metabolites,” Proceedings of the National Academy of Sciences of the United States of America, vol. 89, no. 15, pp. 7105–7109, 1992. View at Publisher · View at Google Scholar · View at Scopus
  14. H. F. Juan, J. W. Hsu, H. C. Huang, S. T. Chen, and C. H. Wong, “Ganoderma lucidum polysaccharides induce macrophage-like differentiation in human leukemia THP-1 cells via caspase and p53 activation,” Evidence-Based Complementary and Alternative Medicine, vol. 2011, Article ID 358717, 13 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  15. Y.-Y. Chen, F.-C. Liu, P.-Y. Chou et al., “Ethanol extracts of fruiting bodies of antrodia cinnamomea suppress CL1-5 human lung adenocarcinoma cells migration by inhibiting matrix metalloproteinase-2/9 through ERK, JNK, p38, and PI3K/Akt signaling pathways,” Evidence-Based Complementary and Alternative Medicine, vol. 2012, Article ID 378415, 11 pages, 2012. View at Publisher · View at Google Scholar
  16. H. Li, L. Guo, S. Jie et al., “Berberine inhibits SDF-1-induced AML cells and leukemic stem cells migration via regulation of SDF-1 level in bone marrow stromal cells,” Biomedicine and Pharmacotherapy, vol. 62, no. 9, pp. 573–578, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. Y. H. Chang, J. S. Yang, J. L. Yang et al., “Ganoderma lucidum extracts inhibited leukemia WEHI-3 cells in BALB/c mice and promoted an immune response in vivo,” Bioscience, Biotechnology and Biochemistry, vol. 73, no. 12, pp. 2589–2594, 2009. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Recher, L. Ysebaert, O. Beyne-Rauzy et al., “Expression of focal adhesion kinase in acute myeloid leukemia is associated with enhanced blast migration, increased cellularity, and poor prognosis,” Cancer Research, vol. 64, no. 9, pp. 3191–3197, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. Sonoda, N. Aiba, R. Utsubo, E. Koguchi, M. Hasegawa, and T. Kasahara, “Induction of antioxidant enzymes by FAK in a human leukemic cell line, HL-60,” Biochimica et Biophysica Acta, vol. 1683, no. 1–3, pp. 22–32, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. Y.-R. Pan, C.-L. Chen, and H.-C. Chen, “FAK is required for the assembly of podosome rosettes,” Journal of Cell Biology, vol. 195, no. 1, pp. 113–129, 2011. View at Publisher · View at Google Scholar
  21. B. T. Hennessy, D. L. Smith, P. T. Ram, Y. Lu, and G. B. Mills, “Exploiting the PI3K/AKT pathway for cancer drug discovery,” Nature Reviews Drug Discovery, vol. 4, no. 12, pp. 988–1004, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. J. LoPiccolo, C. A. Granville, J. J. Gills, and P. A. Dennis, “Targeting Akt in cancer therapy,” Anti-Cancer Drugs, vol. 18, no. 8, pp. 861–874, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. T. Yamadori, Y. Ishii, S. Homma et al., “Molecular mechanisms for the regulation of Nrf2-mediated cell proliferation in non-small-cell lung cancers,” Oncogene, vol. 31, no. 45, pp. 4768–4777, 2012. View at Publisher · View at Google Scholar
  24. J. You, D. Mi, X. Zhou et al., “A positive feedback between activated extracellularly regulated kinase and cyclooxygenase/lipoxygenase maintains proliferation and migration of breast cancer cells,” Endocrinology, vol. 150, no. 4, pp. 1607–1616, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. C.-Y. Chiu, K.-K. Kuo, T.-L. Kuo, K.-T. Lee, and K.-H. Cheng, “The activation of MEK/ERK signaling pathway by bone morphogenetic protein 4 to increase hepatocellular carcinoma cell proliferation and migration,” Molecular Cancer Research, vol. 10, no. 3, pp. 415–427, 2012. View at Publisher · View at Google Scholar
  26. S. C. Kim, J. S. Hahn, Y. H. Min, N. C. Yoo, Y. W. Ko, and W. J. Lee, “Constitutive activation of extracellular signal-regulated kinase in human acute leukemias: combined role of activation of MEK, hyperexpression of extracellular signal-regulated kinase, and downregulation of a phosphatase, PAC1,” Blood, vol. 93, no. 11, pp. 3893–3899, 1999. View at Google Scholar · View at Scopus
  27. N. Giuliani, P. Lunghi, F. Morandi et al., “Downmodulation of ERK protein kinase activity inihibits VEGF secretion by human myeloma cells and myeloma-induced angiogenesis,” Leukemia, vol. 18, no. 3, pp. 628–635, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. C. Nishioka, T. Ikezoe, J. Yang, and A. Yokoyama, “Inhibition of MEK/ERK signaling induces apoptosis of acute myelogenous leukemia cells via inhibition of eukaryotic initiation factor 4E-binding protein 1 and down-regulation of Mcl-1,” Apoptosis, vol. 15, no. 7, pp. 795–804, 2010. View at Publisher · View at Google Scholar · View at Scopus
  29. J. Rodríguez, F. Calvo, J. M. González, B. Casar, V. Andrés, and P. Crespo, “ERK1/2 MAP kinases promote cell cycle entry by rapid, kinase-independent disruption of retinoblastoma-lamin A complexes,” Journal of Cell Biology, vol. 191, no. 5, pp. 967–979, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. W. H. Liu and L. S. Chang, “Caffeine induces matrix metalloproteinase-2 (MMP-2) and MMP-9 down-regulation in human leukemia U937 cells via Ca2+/ROS-mediated suppression of ERK/c-Fos pathway and activation of p38 MAPK/c-Jun pathway,” Journal of Cellular Physiology, vol. 224, no. 3, pp. 775–785, 2010. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Liu, M. H. Lee, M. Cohen, M. Bommakanti, and L. P. Freedman, “Transcriptional activation of the Cdk inhibitor p21 by vitamin D3 leads to the induced differentiation of the myelomonocytic cell line U937,” Genes and Development, vol. 10, no. 2, pp. 142–153, 1996. View at Google Scholar · View at Scopus
  32. F. Chang, J. T. Lee, P. M. Navolanic et al., “Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy,” Leukemia, vol. 17, no. 3, pp. 590–603, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. Y. Li, D. Dowbenko, and L. A. Lasky, “AKT/PKB phosphorylation of p21Cip/Waf1 enhances protein stability of p21Cip/Waf1 and promotes cell survival,” The Journal of Biological Chemistry, vol. 277, no. 13, pp. 11352–11361, 2002. View at Publisher · View at Google Scholar · View at Scopus
  34. E. V. Broude, M. E. Swift, C. Vivo et al., “p21Waf1/Cip1/Sid1 mediates retinoblastoma protein degradation,” Oncogene, vol. 26, no. 48, pp. 6954–6958, 2007. View at Publisher · View at Google Scholar · View at Scopus
  35. A. Pivoriunas, J. Savickiene, G. Treigyte, V. Tunaitis, R. Navakauskiene, and K. E. Magnusson, “PI 3-K signaling pathway suppresses PMA-induced expression of p21Waf1/Cip1 in human leukemia cells,” Molecular and Cellular Biochemistry, vol. 302, no. 1-2, pp. 9–18, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. H. Chen, B. Zhang, Y. Yao et al., “NADPH oxidase-derived reactive oxygen species are involved in the HL-60 cell monocytic differentiation induced by isoliquiritigenin,” Molecules, vol. 17, no. 11, pp. 13424–13438, 2012. View at Publisher · View at Google Scholar
  37. C. Lin and H. Wang, “NADPH oxidase is involved in H2O2-induced differentiation of human promyelocytic leukaemia HL-60 cells,” Cell Biology International, vol. 36, no. 4, pp. 391–395, 2012. View at Publisher · View at Google Scholar
  38. D. Richard, H. Morjani, and B. Chénais, “Free radical production and labile iron pool decrease triggered by subtoxic concentration of aclarubicin in human leukemia cell lines,” Leukemia Research, vol. 26, no. 10, pp. 927–931, 2002. View at Publisher · View at Google Scholar · View at Scopus
  39. H. F. Lu, S. C. Hsueh, Y. T. Ho et al., “ROS mediates baicalin-induced apoptosis in human promyelocytic leukemia HL-60 cells through the expression of the Gadd153 and mitochondrial-dependent pathway,” Anticancer Research, vol. 27, no. 1, pp. 117–126, 2007. View at Google Scholar · View at Scopus
  40. E. Burgos-Morón, J. M. Calderón-Montaño, M. L. Orta et al., “The coffee constituent chlorogenic acid induces cellular DNA damage and formation of topoisomerase I- and II-DNA complexes in cells,” Journal of Agricultural and Food Chemistry, vol. 60, no. 30, pp. 7384–7391, 2012. View at Publisher · View at Google Scholar
  41. M. Segarra, C. Vilardell, K. Matsumoto et al., “Dual function of focal adhesion kinase in regulating integrin-induced MMP-2 and MMP-9 release by human T lymphoid cells,” The FASEB Journal, vol. 19, no. 13, pp. 1875–1877, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Paupert, V. Mansat-De Mas, C. Demur, B. Salles, and C. Muller, “Cell-surface MMP-9 regulates the invasive capacity of leukemia blast cells with monocytic features,” Cell Cycle, vol. 7, no. 8, pp. 1047–1053, 2008. View at Google Scholar · View at Scopus
  43. S. Feng, J. Cen, Y. Huang et al., “Matrix metalloproteinase-2 and -9 secreted by leukemic cells increase the permeability of blood-brain barrier by disrupting tight junction proteins,” PLoS ONE, vol. 6, no. 8, Article ID e20599, 2011. View at Publisher · View at Google Scholar
  44. I. H. Lin, M. C. Lee, and W. C. Chuang, “Application of LC/MS and ICP/MS for establishing the fingerprint spectrum of the traditional Chinese medicinal preparation Gan-Lu-Yin,” Journal of Separation Science, vol. 29, no. 1, pp. 172–179, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. J. J. Liu, T. S. Huang, W. F. Cheng, and F. J. Lu, “Baicalein and baicalin are potent inhibitors of angiogenesis: inhibition of endothelial cell proliferation, migration and differentiation,” International Journal of Cancer, vol. 106, no. 4, pp. 559–565, 2003. View at Publisher · View at Google Scholar · View at Scopus
  46. T. Ikezoe, S. S. Chen, D. Heber, H. Taguchi, and H. P. Koeffler, “Baicalin is a major component of PC-SPES which inhibits the proliferation of human cancer cells via apoptosis and cell cycle arrest,” Journal of Urology, vol. 168, no. 1, pp. 379–380, 2002. View at Google Scholar
  47. K. Zhang, Q. L. Guo, Q. D. You et al., “Wogonin induces the granulocytic differentiation of human NB4 promyelocytic leukemia cells and up-regulates phospholipid scramblase 1 gene expression,” Cancer Science, vol. 99, no. 4, pp. 689–695, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. U. H. Jin, J. Y. Lee, S. K. Kang et al., “A phenolic compound, 5-caffeoylquinic acid (chlorogenic acid), is a new type and strong matrix metalloproteinase-9 inhibitor: isolation and identification from methanol extract of Euonymus alatus,” Life Sciences, vol. 77, no. 22, pp. 2760–2769, 2005. View at Publisher · View at Google Scholar · View at Scopus
  49. K. Yagasaki, Y. Miura, R. Okauchi, and T. Furuse, “Inhibitory effects of chlorogenic acid and its related compounds on the invasion of hepatoma cells in culture,” Cytotechnology, vol. 33, no. 1–3, pp. 229–235, 2000. View at Google Scholar · View at Scopus
  50. T. Tanaka, T. Kojima, T. Kawamori et al., “Inhibition of 4-nitroquinoline-1-oxide-induced rat tongue carcinogenesis by the naturally occurring plant phenolics caffeic, ellagic, chlorogenic and ferulic acids,” Carcinogenesis, vol. 14, no. 7, pp. 1321–1325, 1993. View at Google Scholar · View at Scopus
  51. J. M. Cherng, K. D. Tsai, Y. W. Yu, and J. C. Lin, “Molecular mechanisms underlying chemopreventive activities of glycyrrhizic acid against UVB-radiation-induced carcinogenesis in SKH-1 hairless mouse epidermis,” Radiation Research, vol. 176, no. 2, pp. 177–186, 2011. View at Publisher · View at Google Scholar · View at Scopus
  52. S. Thiugnanam, L. Xu, K. Ramaswamy, and M. Gnanasekar, “Glycyrrhizin induces apoptosis in prostate cancer cell lines DU-145 and LNCaP,” Oncology Reports, vol. 20, no. 6, pp. 1387–1392, 2008. View at Publisher · View at Google Scholar · View at Scopus
  53. A. W. Harmon and Y. M. Patel, “Naringenin inhibits glucose uptake in MCF-7 breast cancer cells: a mechanism for impaired cellular proliferation,” Breast Cancer Research and Treatment, vol. 85, no. 2, pp. 103–110, 2004. View at Publisher · View at Google Scholar · View at Scopus
  54. S. I. Kanno, A. Tomizawa, T. Hiura et al., “Inhibitory effects of naringenin on tumor growth in human cancer cell lines and sarcoma S-180-implanted mice,” Biological and Pharmaceutical Bulletin, vol. 28, no. 3, pp. 527–530, 2005. View at Publisher · View at Google Scholar · View at Scopus
  55. H. Luo, B. H. Jiang, S. M. King, and Y. C. Chen, “Inhibition of cell growth and VEGF expression in ovarian cancer cells by flavonoids,” Nutrition and Cancer, vol. 60, no. 6, pp. 800–809, 2008. View at Publisher · View at Google Scholar · View at Scopus
  56. C. M. Lin, H. Chang, Y. H. Chen, I. H. Wu, and J. H. Chiu, “Wogonin inhibits IL-6-induced angiogenesis via down-regulation of VEGF and VEGFR-1, not VEGFR-2,” Planta Medica, vol. 72, no. 14, pp. 1305–1310, 2006. View at Publisher · View at Google Scholar · View at Scopus
  57. N. Lu, Y. Gao, Y. Ling et al., “Wogonin suppresses tumor growth in vivo and VEGF-induced angiogenesis through inhibiting tyrosine phosphorylation of VEGFR2,” Life Sciences, vol. 82, no. 17-18, pp. 956–963, 2008. View at Publisher · View at Google Scholar · View at Scopus
  58. H. R. Frydoonfar, D. R. McGrath, and A. D. Spigelman, “The variable effect on proliferation of a colon cancer cell line by the citrus fruit flavonoid Naringenin,” Colorectal Disease, vol. 5, no. 2, pp. 149–152, 2003. View at Publisher · View at Google Scholar · View at Scopus
  59. G. Ekambaram, P. Rajendran, V. Magesh, and D. Sakthisekaran, “Naringenin reduces tumor size and weight lost in N-methyl-N′-nitro-N-nitrosoguanidine-induced gastric carcinogenesis in rats,” Nutrition Research, vol. 28, no. 2, pp. 106–112, 2008. View at Publisher · View at Google Scholar · View at Scopus
  60. K. Lirdprapamongkol, H. Sakurai, N. Kawasaki et al., “Vanillin suppresses in vitro invasion and in vivo metastasis of mouse breast cancer cells,” European Journal of Pharmaceutical Sciences, vol. 25, no. 1, pp. 57–65, 2005. View at Publisher · View at Google Scholar · View at Scopus
  61. J. A. Liang, S. L. Wu, H. Y. Lo, C. Y. Hsiang, and T. Y. Ho, “Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-κB signaling pathway in human hepatocellular carcinoma cells,” Molecular Pharmacology, vol. 75, no. 1, pp. 151–157, 2009. View at Publisher · View at Google Scholar · View at Scopus
  62. K. Lirdprapamongkol, J. P. Kramb, T. Suthiphongchai et al., “Vanillin suppresses metastatic potential of human cancer cells through PI3K inhibition and decreases angiogenesis in vivo,” Journal of Agricultural and Food Chemistry, vol. 57, no. 8, pp. 3055–3063, 2009. View at Publisher · View at Google Scholar · View at Scopus
  63. D. Nie, S. Krishnamoorthy, R. Jin et al., “Mechanisms regulating tumor angiogenesis by 12-lipoxygenase in prostate cancer cells,” The Journal of Biological Chemistry, vol. 281, no. 27, pp. 18601–18609, 2006. View at Publisher · View at Google Scholar · View at Scopus
  64. A. Belkaid, J. C. Currie, J. Desgagnés, and B. Annabi, “The chemopreventive properties of chlorogenic acid reveal a potential new role for the microsomal glucose-6-phosphate translocase in brain tumor progression,” Cancer Cell International, vol. 6, article 7, 2006. View at Publisher · View at Google Scholar · View at Scopus